| |
|
|
|
Therapix Biosciences Ltd.  
|
|
5.25 -0.47 (-0.08%) |
09-21 16:00 |
|
Open: |
5.5 |
Pre close: |
5.72 |
Target:
|
6.83 
|
|
High: |
5.85 |
Low: |
4.6388 |
Resistance:
|
5.85
6.83
|
|
Volume: |
510,547 |
Market Cap: |
18M |
Support:
|
4.32
3.37
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.56
|
MACD |
MACD(12,26):
|
0.23 |
|
MA(20): |
4.23 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
4.03 |
Stochastic Oscillator |
%K(14,3):
|
63.34 |
|
MA(250): |
4.90  |
%D(3): |
42.96 |
|
Average Volume(K) |
3-Month: |
11641
|
52-Week |
High:
|
7.69 |
|
10-Days: |
19842 |
Low: |
3.00 |
|
RSI |
RSI(14):
|
64.30 |
Change(%): |
-5.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-83.3 |
Shares Out. (M) |
3.50 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
-74.9 |
Shares Float (M) |
3.50 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.30 |
|
Forward EPS |
-2.158 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
176 |
|
Book Value (p.s.) |
2.580 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.94 |
P/CF |
-3.09 |
|
|
|
|
|
|
